Noninvasive tests performed in midlife may help identify people who are at risk of late-onset epilepsy (LOE), a new study suggests. New data from the Framingham Heart Study show those who scored ...
Takeda’s late-phase epilepsy program has failed a key test, chalking up misses on the primary endpoints in pivotal trials in two indications. But the Japanese drugmaker still plans to talk to ...
Diagnosing epilepsy involves a review of your medical history. You may have neurological testing and blood tests done. Blood tests can check for infections or genetic conditions. Several measures of ...
The Epilepsy Program at University of Utah Health is dedicated to improving the lives of people with epilepsy through innovative research and clinical trials. Our experts are at the forefront of ...
A new clinical trial co-led by researchers at FutureNeuro and RCSI University of Medicine and Health Sciences is investigating how advanced brain monitoring could improve the diagnosis and management ...
A simple saliva test could transform the lives of millions of children and adults worldwide who are on the keto diet to manage their epilepsy, and who currently endure uncomfortable finger prick tests ...
The University of Utah College of Pharmacy's Anticonvulsant Drug Development (ADD) Program has been awarded a five-year $19.5 million contract renewal with the National Institutes of Health (NIH) to ...
Researchers from Lund University in Sweden have discovered higher levels of immune proteins in the blood before and after an epileptic seizure. The possible biomarkers can be identified using a simple ...
Epilepsy patients receiving treatment at AIIMS will no longer have to rely on private laboratories for critical blood tests, with the institute rolling out free Therapeutic Drug Monitoring (TDM) for ...
Autoimmune epilepsy is a newly defined group of conditions characterized by recurrent seizures associated with autoimmunity. Cancer and infections are two potential triggers. Epilepsy is a seizure ...
The All India Institute of Medical Sciences has introduced a free therapeutic drug monitoring test for patients with epilepsy, the institute said. Epilepsy is a chronic brain disorder causing ...